Partner to the healthcare and pharma industry, Gerresheimer has announced it will complete its product portfolio of prefillable syringes through an exclusive licence from West Pharmaceutical Services.
Needlestick
The syringe, developed by West, features an integrated passive syringe safety solution to help reduce needlestick-related injuries.
Uwe Röhrhoff, CEO of Gerresheimer said: “As a result of our long-standing partnership with the leading manufacturer of packaging components and delivery devices for parenteral drugs we are pleased to have acquired the rights to market this innovative, new syringe safety solution, developed by West. By doing so, we will complement our very broad range of prefillable syringe solutions for biotech and other drugs.”
The new safety solution is fully compatible with Gerresheimer’s ready-to-fill (RTF) syringe portfolio. The solution is fully integrated and will be assembled on the syringe in the production process. It is compliant with standard nests and tubs, which enables the pharmaceutical company to use the standard filling process.
